Navigation Links
Arthritis sufferers fund arthritis research
Date:2/19/2008

The Queensland and Northern New South Wales Lions Medical Research Foundation, long time supporters of the Brisbane research community, have confirmed funding of $1.2 million for scientists at UQ's Diamantina Institute.

Dr Gethin Thomas will be the inaugural recipient of the $300,000 three-year fellowship, which will fund his research investigating the causes of ankylosing spondylitis (AS).

This is a form of arthritis affecting the spine resulting in joint fusion and immobility, and osteoporosis, a disease characterised by bone loss and frequent fracture.

This funding will enable us to focus on our longer-term goals of identifying the underlying causes of these diseases and developing new drugs and therapies, Dr Thomas said.

There is an urgent need for new therapies in these diseases that will enable reversal of disease damage.

The current therapies can only prevent progression of AS and osteoporosis but cannot repair already damaged bones and joints.

Unfortunately sufferers are frequently not diagnosed until fracture or loss of mobility by which time degeneration of the bones or joints is already significant.

Irene Dunning, Lions Foundation Chairman, said she was pleased Dr Thomas had received the first installment of the new Fellowship.

I think it's good to be supporting something which will potentially help a lot of Lions members," she said.

Osteoporosis and arthritis are diseases that affect many Lions members and their families and friends.

Lions members will further contribute to the research by volunteering as participants in the studies providing a valuable resource for our research efforts and creating a mutually beneficial synergy.


'/>"/>

Contact: Penny Robinson
penny.robinson@uq.edu.au
61-733-659-723
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Study Suggests Glucosamine Wont Ease Hip Arthritis
2. Gene Linked to Inflammatory Arthritis Also Raises Heart Risks
3. Rheumatoid arthritis sends many into early retirement
4. Depression not discussed during rheumatoid arthritis doctor visits
5. The HLA-DRB1 gene and premature death in rheumatoid arthritis
6. Newer Rheumatoid Arthritis Drugs Lower Production of B Cells
7. Popular arthritis drug may disrupt heart rhythm, UB research finds
8. Exercise Program Eases Arthritis
9. A new view of drugs used to treat rheumatoid arthritis
10. Genes Linked to Height Also Tied to Osteoarthritis Risk
11. Modified-Release Prednisone May Ease Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... January 15, 2017 , ... ... physicians in eight Bay Area counties for 2017. Almost 1,000 nominations were submitted ... managing the award process. Results were announced the magazine’s January 2017 issue ...
(Date:1/14/2017)... ... 14, 2017 , ... Healthy living brand Moody Zook recently ... products. With more and more people opting to go organic in their lifestyle, ... cater to specific needs. , Moody Zook focused particularly on their newly launched ...
(Date:1/13/2017)... ... January 13, 2017 , ... ... sugar levels. Counting carbohydrates is as easy as checking the nutrition label on ... affects blood sugar levels. Despite being sugar-free, proteins can influence — either positively ...
(Date:1/13/2017)... ... January 13, 2017 , ... With the increasing public preference ... providing additional organic alternatives for customers who have grown more conscious about maintaining ... of all-natural activated charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained ...
(Date:1/13/2017)... ... ... "We wanted to create a design for orthodontic appliances that would make ... Beach, Va. , They created a prototype for the patent-pending BRACE FACERS to add ... be customized to suit personal tastes. They can be used to create custom designs ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... January 13, 2017 Constant research ongoing ... will collectively contribute to the demand for western blotting technique. ... value of US$ 551.0 Mn by 2016 end. Developing economies ... most lucrative markets for western blotting, whereas North ... ...
(Date:1/13/2017)... NEW YORK , January 13, 2017 ... Biotech equities to see how they have fared at ... CLVS ), Galena Biopharma Inc. (NASDAQ: GALE ... ). These companies harness cellular and biomolecular processes to ... diseases, reduce our environmental footprint, feed the hungry, use ...
(Date:1/13/2017)... 2017   JDRF , the leading global ... pleased to announce that after more than a ... & Medicaid Services (CMS) has recognized continuous glucose ... use in making diabetes treatment decisions as durable ... eligible for coverage under Medicare. JDRF has been ...
Breaking Medicine Technology: